We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

GLW:NYSECorning Incorporated Analysis

Data as of 2026-08-29 - not real-time

$148.98

Latest Price

9/10Risk

Risk Level: High

Executive Summary

At $148.98, Corning Incorporated shows no decisive moving-average alignment, leaving the trend neutral. Over a rolling month the price has lost 3.6%. With RSI at 44.6 the momentum picture is neutral, alongside a bullish MACD signal. Watch $132.89 as support and $176.94 as the nearer resistance level.
On valuation the read is overvalued — earnings multiple of 68.7 versus a 35.7 sector average, above the peer group. The average analyst target implies 28.5% above today's level. Revenue is growing at 16.6% on a 11.2% profit margin. The 0.73% dividend yield looks covered by current payout levels.
On a 1-10 scale the risk profile lands at 9 — high. With 30-day volatility of 80.0%, a beta of 2.80 and a maximum drawdown of 51.5%, position sizing matters more than entry timing here. The wider market backdrop reads extreme greed at 96 on the fear-greed composite.
All three time horizons resolve to hold, carrying 1/10 conviction.

Top Market Events

Corning Inc. GLW stock is surging on Tuesday as part of a strong post-earnings relief rally. The move is further fueled...Corning Incorporated NYSE:GLW delivered rapid optical growth on July 28, then suffered a share-price decline of more...Corning Inc GLW reports a robust 17% revenue increase and 30% EPS growth, driven by significant gains in Optical...

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 2/10

Key Factors

  • Trading above the 200-day average of 142.20
  • MACD momentum is positive
  • 30-day volatility of 80.0%

Medium Term

1–3 years
Neutral
Model confidence: 1/10

Key Factors

  • P/E of 68.7 versus sector average of 35.7
  • Trading above the 200-day average of 142.20
  • Analyst targets imply +28.5% versus the current price

Long Term

> 3 years
Neutral
Model confidence: 1/10

Key Factors

  • P/E of 68.7 versus sector average of 35.7
  • Analyst targets imply +28.5% versus the current price
  • Revenue growth of +16.6%

Key Metrics & Analysis

Financial Health

Revenue Growth16.60%
Profit Margin11.20%
P/E Ratio68.7
ROE16.81%
ROA5.37%
Debt/Equity71.45
P/B Ratio10.7
Op. Cash Flow$3.9B
Free Cash Flow$734.5M
Industry P/E35.7

Technical Analysis

TrendNeutral
RSI44.6
Support$132.89
Resistance$176.94
MA 20$156.46
MA 50$171.12
MA 200$142.20
MACDBullish
VolumeDecreasing
Fear & Greed Index95.66

Valuation

Fair Value$13.72
Target Price$191.40
Upside/Downside28.47%
GradeOvervalued
TypeGrowth
Dividend Yield0.73%

Risk Assessment

Beta2.80
Volatility79.97%
Sector RiskHigh
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.